European Commission Approves EFIENT(R) (prasugrel) for Patients …
FOXBusiness
Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted marketing authorization for EFIENT(R) (prasugrel) for the prevention of atherothrombotic events in patients with …
Lilly and Daiichi win European approval for blood thinner drug Trading Markets (press release)
Lilly blood thinner prasugrel earns EU approval Forbes
Daiichi, Lilly win European approval for prasugrel Reuters
Bloomberg - Wall Street Journal Blogs
all 59 news articles